Emergent BioSolutions
Premium PartnerDrug Product
Analytical & Bioanalytical Services
Company Overview
About
Emergent BioSolutions is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals
Therapeutic Areas
Cardiovascular
Endocrinology
Quick Facts
HQ:Canada
Founded:1999
Employees:2,194
Capabilities & Services
Core Capabilities
- Sterile Injectable
- Sterile Fill/Finish
- Fill/Finish (Vials)
Technology Platforms
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Cartridge / Pen
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
Asia-Pacific
Manufacturing Facilities
2 sites worldwide
Emergent BioSolutions - Canada Facility
Canada
Site Capabilities
Solid Dose Manufacturing
Oral Liquids
Topicals
Emergent BioSolutions - United States Facility
United States
Site Capabilities
Solid Dose Manufacturing
Oral Liquids
Topicals
Regulatory Approvals
Drug Approval QQQQK7
EMA · #APR-DOB8QEV9 · 2022-04-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-D837CIFH
Issued: 2020-07-18
Expires: 2025-04-10
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-GPBQ3SQJ
Issued: 2020-05-01
Expires: 2025-02-23
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-8TANIVCE
Issued: 2020-08-09
Expires: 2025-05-22
Customer Reviews
4.1
Overall Rating
Project Management4.9
Technology Transfer3.5
On-Time Delivery3.9
Communication Responsiveness3.7
Innovation4.4
Company Documents
No documents available.
Loading CDMO intelligence...